galactaric acid has been researched along with camptothecin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, ME; Han, H | 2 |
| Davis, ME; Wyatt, EA | 1 |
3 other study(ies) available for galactaric acid and camptothecin
| Article | Year |
|---|---|
Targeted nanoparticles assembled via complexation of boronic-acid-containing targeting moieties to diol-containing polymers.
Topics: Animals; Antineoplastic Agents; Blood Circulation; Boronic Acids; Camptothecin; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Delivery Systems; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Molecular Structure; Molecular Weight; Nanoparticles; Particle Size; Polyethylene Glycols; Polymers; Structure-Activity Relationship; Sugar Acids; Surface Properties | 2013 |
Single-antibody, targeted nanoparticle delivery of camptothecin.
Topics: Animals; Antibodies, Monoclonal, Humanized; Camptothecin; Chromatography, High Pressure Liquid; Drug Carriers; Female; Humans; Mice; Mice, Nude; Nanoparticles; Polymers; Sugar Acids; Trastuzumab | 2013 |
Nanoparticles Containing a Combination of a Drug and an Antibody for the Treatment of Breast Cancer Brain Metastases.
Topics: Animals; Antineoplastic Agents, Immunological; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Camptothecin; Cell Line, Tumor; Drug Combinations; Drug Delivery Systems; Female; Humans; Mice; Nanoparticles; Sugar Acids; Trastuzumab; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |